XML 67 R36.htm IDEA: XBRL DOCUMENT v3.25.4
Derivative Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
(in thousands)December 31,
ExecutionMaturityDesignation20252024
October 2019(1)(2)
September 2026Not designated$2,800,000 $2,800,000 
March 2023March 2028Not designated100,000 100,000 
April 2023March 2028Not designated200,000 200,000 
December 2023(2)
September 2026Not designated700,000 700,000 
June 2025(3)
March 2032
Cash flow hedge
550,000 — 
July 2025(3)
March 2032
Cash flow hedge
500,000 — 
July 2025
March 2032
Not designated100,000 — 
September 2025(4)
October 2030
Cash flow hedge
200,000 — 
October 2025(3)
December 2030
Cash flow hedge
100,000 — 
October 2025(3)
March 2032
Cash flow hedge
200,000 — 
October 2025(4)
December 2027
Cash flow hedge
1,400,000 — 
Total notional amount$6,850,000 $3,800,000 
___________________
(1)These swaps contain an other-than-insignificant financing element due to their off-market terms at the inception. Prior to March 2020, these swaps were designated as cash flow hedges.
(2)The December 2023 swaps were entered into to offset the excess notional interest rate swaps as a result of the partial redemption of the then outstanding First Lien Term Loan B due 2026 in connection with the Commercial Divestiture. The changes in fair value associated with these swaps and a portion of the October 2019 swaps are reflected in other income (expense).
(3)These swaps were entered into to hedge the interest rate variability on the Company’s First Lien Term Loan B-2 due 2032 or its direct replacement.
(4)These forward-starting swaps were entered into to hedge the interest rate variability on the Company’s First Lien Term Loan B due 2030 or its direct replacement with the swap settlement periods commencing in September 2026.
Schedule of Derivative Liabilities at Fair Value
Classification and Fair Value
December 31,
Balance Sheet Classification (in thousands)
20252024
Prepaid expenses and other current assets$38,264 $56,164 
Other assets3,722 54,102 
Accrued expenses and other current liabilities(1,044)(1,466)
Other liabilities(3,187)(208)
Fair value of interest rate swaps - net asset (liability)$37,755 $108,592 
Schedule of Unrealized Gain (Loss) on Interest Rate Swaps
Unrealized Gains (Losses)

Years Ended December 31,
Statement of Operations Classification (in thousands)
202520242023
Interest expense, net
$(55,984)$(27,164)$(22,174)
Other income (expense)
$(15,461)$(17,996)$(16,511)
Schedule of Accumulated Other Comprehensive Loss
Changes in and Reclassifications out of AOCI
(in thousands)
Balance as of December 31, 2022$(45,513)
Pre-tax current period change42,295 
Income tax benefit (expense)(10,166)
Balance as of December 31, 2023(13,384)
Pre-tax current period change7,921 
Income tax benefit (expense)(1,913)
Balance as of December 31, 2024(7,376)
Pre-tax current period change7,323 
Income tax benefit (expense)(1,766)
Balance as of December 31, 2025$(1,819)